Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Glaukos Co. stock logo
GKOS
Glaukos
$96.62
+1.2%
$102.37
$77.91
$163.71
$5.47B0.88646,054 shs545,203 shs
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$26.65
-1.3%
$27.52
$23.69
$31.72
$11.67B0.71823,199 shs928,869 shs
Solventum Co. stock logo
SOLV
Solventum
$66.14
-2.1%
$72.58
$47.16
$85.92
$11.44BN/A1.30 million shs672,816 shs
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$101.46
0.0%
$105.81
$93.10
$123.96
$20.07B0.841.67 million shs1.66 million shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Glaukos Co. stock logo
GKOS
Glaukos
+1.49%+7.17%-6.43%-39.80%-4.37%
Smith & Nephew plc stock logo
SNN
Smith & Nephew
-1.30%+2.90%-6.21%+6.22%+8.47%
Solventum Co. stock logo
SOLV
Solventum
-2.04%-0.13%-10.92%-11.73%+4.09%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
-0.04%+3.64%-8.26%-8.41%-16.27%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Glaukos Co. stock logo
GKOS
Glaukos
4.6585 of 5 stars
4.54.00.04.42.12.50.6
Smith & Nephew plc stock logo
SNN
Smith & Nephew
2.0004 of 5 stars
1.03.02.50.02.30.03.1
Solventum Co. stock logo
SOLV
Solventum
1.3561 of 5 stars
3.03.00.00.02.30.00.0
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
4.7094 of 5 stars
3.25.01.73.73.42.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Glaukos Co. stock logo
GKOS
Glaukos
2.92
Moderate Buy$156.1761.63% Upside
Smith & Nephew plc stock logo
SNN
Smith & Nephew
2.00
Hold$27.001.31% Upside
Solventum Co. stock logo
SOLV
Solventum
2.00
Hold$79.8620.74% Upside
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
2.32
Hold$124.1522.36% Upside

Current Analyst Ratings Breakdown

Latest GKOS, ZBH, SNN, and SOLV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/25/2025
Smith & Nephew plc stock logo
SNN
Smith & Nephew
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
4/16/2025
Glaukos Co. stock logo
GKOS
Glaukos
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$200.00 ➝ $175.00
4/15/2025
Glaukos Co. stock logo
GKOS
Glaukos
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$180.00 ➝ $165.00
4/14/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
4/11/2025
Glaukos Co. stock logo
GKOS
Glaukos
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$185.00 ➝ $140.00
3/17/2025
Smith & Nephew plc stock logo
SNN
Smith & Nephew
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold$27.00 ➝ $27.00
3/12/2025
Smith & Nephew plc stock logo
SNN
Smith & Nephew
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
3/5/2025
Solventum Co. stock logo
SOLV
Solventum
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$73.00 ➝ $80.00
3/3/2025
Solventum Co. stock logo
SOLV
Solventum
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$70.00 ➝ $82.00
3/3/2025
Solventum Co. stock logo
SOLV
Solventum
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSell ➝ Sell$63.00 ➝ $71.00
2/28/2025
Solventum Co. stock logo
SOLV
Solventum
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$73.00 ➝ $75.00
(Data available from 4/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Glaukos Co. stock logo
GKOS
Glaukos
$383.48M14.25N/AN/A$9.46 per share10.21
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$5.81B2.01$3.33 per share8.00$11.94 per share2.23
Solventum Co. stock logo
SOLV
Solventum
$8.25B1.39N/AN/AN/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$7.68B2.61$12.92 per share7.85$62.67 per share1.62
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Glaukos Co. stock logo
GKOS
Glaukos
-$134.66M-$2.87N/AN/AN/A-39.04%-16.53%-10.61%4/30/2025 (Estimated)
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$263M$2.1612.3413.331.26N/AN/AN/AN/A
Solventum Co. stock logo
SOLV
Solventum
N/A$2.7524.0512.051.94N/AN/AN/A5/8/2025 (Estimated)
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$903.70M$4.4522.8011.441.9511.77%12.99%7.58%5/5/2025 (Estimated)

Latest GKOS, ZBH, SNN, and SOLV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Solventum Co. stock logo
SOLV
Solventum
$1.19N/AN/AN/A$2.02 billionN/A
5/5/2025Q1 2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$1.77N/AN/AN/A$1.89 billionN/A
4/30/2025Q1 2025
Glaukos Co. stock logo
GKOS
Glaukos
-$0.33N/AN/AN/A$102.78 millionN/A
2/20/2025Q4 2024
Glaukos Co. stock logo
GKOS
Glaukos
-$0.38-$0.40-$0.02-$0.60$100.72 million$105.50 million
2/6/2025Q4 2024
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$2.30$2.31+$0.01$1.20$2.01 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Glaukos Co. stock logo
GKOS
Glaukos
N/AN/AN/AN/AN/A
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$0.893.34%N/A41.20%N/A
Solventum Co. stock logo
SOLV
Solventum
N/AN/AN/AN/AN/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$0.960.95%N/A21.57%N/A

Latest GKOS, ZBH, SNN, and SOLV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/26/2025
Smith & Nephew plc stock logo
SNN
Smith & Nephew
semi-annual$0.44702.5%3/28/20253/28/20255/28/2025
2/26/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
quarterly$0.240.89%3/31/20253/31/20254/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Glaukos Co. stock logo
GKOS
Glaukos
0.19
5.54
4.71
Smith & Nephew plc stock logo
SNN
Smith & Nephew
0.63
2.51
1.11
Solventum Co. stock logo
SOLV
Solventum
2.45
1.15
0.83
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.43
1.91
0.99

Institutional Ownership

CompanyInstitutional Ownership
Glaukos Co. stock logo
GKOS
Glaukos
99.04%
Smith & Nephew plc stock logo
SNN
Smith & Nephew
25.64%
Solventum Co. stock logo
SOLV
Solventum
N/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
88.89%

Insider Ownership

CompanyInsider Ownership
Glaukos Co. stock logo
GKOS
Glaukos
6.40%
Smith & Nephew plc stock logo
SNN
Smith & Nephew
1.00%
Solventum Co. stock logo
SOLV
Solventum
0.05%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Glaukos Co. stock logo
GKOS
Glaukos
78056.57 million51.61 millionOptionable
Smith & Nephew plc stock logo
SNN
Smith & Nephew
20,100437.96 million432.83 millionOptionable
Solventum Co. stock logo
SOLV
Solventum
22,000173.00 millionN/AOptionable
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
18,000197.84 million197.18 millionOptionable

Recent News About These Companies

Zimmer Biomet acquires Paragon 28
Zimmer Biomet completes Paragon 28 acquisition

New MarketBeat Followers Over Time

Media Sentiment Over Time

Glaukos stock logo

Glaukos NYSE:GKOS

$96.62 +1.19 (+1.25%)
Closing price 04/25/2025 03:59 PM Eastern
Extended Trading
$96.64 +0.02 (+0.02%)
As of 04/25/2025 06:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Smith & Nephew stock logo

Smith & Nephew NYSE:SNN

$26.65 -0.35 (-1.30%)
Closing price 04/25/2025 03:59 PM Eastern
Extended Trading
$26.64 -0.01 (-0.06%)
As of 04/25/2025 04:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

Solventum stock logo

Solventum NYSE:SOLV

$66.14 -1.39 (-2.06%)
Closing price 04/25/2025 03:59 PM Eastern
Extended Trading
$66.70 +0.56 (+0.85%)
As of 04/25/2025 06:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

Zimmer Biomet stock logo

Zimmer Biomet NYSE:ZBH

$101.46 -0.04 (-0.04%)
Closing price 04/25/2025 03:59 PM Eastern
Extended Trading
$101.50 +0.04 (+0.04%)
As of 04/25/2025 05:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.